Opaleye-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
45
Total Value
449152370
Accession Number
0001641172-25-010914
Form Type
13F-HR
Manager Name
Opaleye-Management
Data Enrichment
91% identified
41 identified4 unidentified

Holdings

45 positions
Manager:
Search and click to pin securities to the top
Page 2 of 3
ANAPTYSBIO, INC
Shares:250.9K
Value:$4.7M
48576UAA4
Shares:
Value:$4.6M
Disc Medicine, Inc.
Shares:85.0K
Value:$4.2M
Larimar Therapeutics, Inc.
Shares:1.9M
Value:$4.1M
CG Oncology, Inc.
Shares:164.0K
Value:$4.0M
ACELYRIN, Inc.
Shares:1.6M
Value:$4.0M
AVITA Medical, Inc.
Shares:440.0K
Value:$3.6M
ESSA Pharma Inc.
Shares:2.2M
Value:$3.5M
Zentalis Pharmaceuticals, Inc.
Shares:2.0M
Value:$3.2M
CARGO Therapeutics, Inc.
Shares:666.5K
Value:$2.7M
Zymeworks Inc.
Shares:175.0K
Value:$2.1M
BIODESIX INC
Shares:3.2M
Value:$2.0M
Stoke Therapeutics, Inc.
Shares:300.0K
Value:$2.0M
MBX Biosciences, Inc.
Shares:250.0K
Value:$1.8M
OptiNose, Inc.
Shares:193.0K
Value:$1.8M
67577R102
Shares:1.2M
Value:$1.5M
iBio, Inc.
Shares:375.0K
Value:$1.5M
Kiniksa Pharmaceuticals International, plc
Shares:62.5K
Value:$1.4M
Nurix Therapeutics, Inc.
Shares:115.0K
Value:$1.4M
Rezolute, Inc.
Shares:465.0K
Value:$1.3M